Skip to main content

Amedisys Inc

Exchange: NASDAQSector: HealthcareIndustry: Medical Care Facilities

Amedisys, Inc. is a leading healthcare at home company delivering personalized home health, hospice and high-acuity care services. Amedisys is focused on delivering the care that is best for our patients, whether that is inpatient hospital, palliative, and skilled nursing facility (“SNF”) care in their homes; home-based recovery and rehabilitation after an operation or injury; care focused on empowering them to manage a chronic disease; or hospice care at the end of life. Nearly 3,000 hospitals and more than 110,000 physicians nationwide have chosen Amedisys as a partner in post-acute care. Founded in 1982, headquartered in Baton Rouge, LA with an executive office in Nashville, TN, Amedisys is a publicly held company. With approximately 19,000 employees in 521 care centers in 37 states and the District of Columbia, Amedisys is dedicated to delivering the highest quality of care to the doorsteps of nearly 470,000 patients in need every year, performing more than 10.6 million visits annually.

Did you know?

Net income compounded at -15.6% annually over 6 years.

Current Price

$100.99

+0.01%

GoodMoat Value

$205.64

103.6% undervalued
Profile
Valuation (TTM)
Market Cap$3.31B
P/E38.71
EV
P/B2.92
Shares Out32.82M
P/Sales1.38
Revenue$2.40B
EV/EBITDA14.14

Amedisys Inc (AMED) Financial Statements

AMED Financial Data

EBITDA$242.38M
Revenue (TTM)$2.40B
Gross Profit (TTM)$1.04B
Gross Margin
Operating Margin4.03%
ROE7.55%
ROA4.00%
Debt/Equity0.40
Current Ratio1.23
FCF$215.12M
FCF Yield6.49%
Piotroski F-Score
Rev/Share (TTM)$73.20
50-Day MA$97.76
200-Day MA
Shares Outstanding0.03B

AMED Computed Insights

FCF$215.12M
FCF Growth Rate-0.14%
EPS Growth (CAGR)-15.57%
WACC10.00%

Income Statement

Balance Sheet

Cash Flow Statement

AMED Financial Statements & Data

Amedisys Inc (AMED) financial data including income statement, balance sheet, and cash flow statement. This page provides a comprehensive view of Amedisys Inc's financial performance and position as a Healthcare company.

Trailing twelve-month (TTM) revenue is $2.40B. Gross profit (TTM) is $1.04B. EBITDA is $242.38M. Earnings per share (EPS) is $1.31. The P/E ratio is 38.71. Market capitalization is $3.31B.

Free cash flow (FCF) is $215.12M. FCF growth rate is -0.14%. EPS growth CAGR is -15.57%. Weighted average cost of capital (WACC) is 10.00%.

Historical revenue data covers 7 years from FY18 to FY24. Net income history spans 7 years. Free cash flow and capital expenditure data spans 7 years. GoodMoat displays interactive charts for revenue, net income, FCF vs CAPEX, and cash-to-debt ratios to help investors identify financial trends.

Use Amedisys Inc's financial data to assess the company's earnings quality, balance sheet health, and cash generation. Compare key metrics across periods to identify trends before making investment decisions with GoodMoat's valuation tools.